Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

Author(s):
Kriege, M.; Hollestelle, A.; Jager, A.; Huijts, P.E.A.; Berns, E.M.; Sieuwerts, A.M.; Meijer-van Gelder, M.E.; Collee, J.M.; Devilee, P. (0000-0002-8023-2009); Hooning, M.J.; Martens, J.W.M.; Seynaeve, C.
Published
2014
Publication type
Article / Letter to editor
adjuvant chemotherapybreast cancerCHEK2 1100delCcontralateral breast cancersurvival
Date issued
2014-08-26
Language
English
Is part of
British Journal of Cancer (2014), Vol. 111, no. 5, p. 1004-1013
hdl
1887/105488
doi
10.1038/bjc.2014.306